News | December 31, 2023
Roche to buy LumiraDx’s technology platform for US$ 295 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
Furthering cell therapy ambition across oncology and autoimmune diseases
Express Scripts to add Zepbound to National Preferred Formulary
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
European operations' revenue grew 58.4% to Rs 599.7 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Subscribe To Our Newsletter & Stay Updated
